Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Frontiers in Oncology|May 3, 2021
Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant MelanomaTeresa Schmidt, Sied Kebir, Elisabeth Livingstone, et al.World Neurosurgery|June 1, 2021
HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain MetastasesAnna Michel, Marvin Darkwah Oppong, Laurèl Rauschenbach, et al.Cancers|March 28, 2024
Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger PatientsHanah Hadice Gull, Antonia Carlotta Von Riegen, Greta Theresa Beckmann, et al.Journal of Applied Clinical Medical Physics|January 3, 2021
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trialYouness Nour, Christoph Pöttgen, Sied Kebir, et al.Journal of Cancer Research and Clinical Oncology|August 11, 2022
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent gliomaLazaros Lazaridis, Teresa Schmidt, Christoph Oster, et al.Journal of Cancer Research and Clinical Oncology|December 13, 2019
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastomaLazaros Lazaridis, Niklas Schäfer, Sarah Teuber-Hanselmann, et al.Clinical Nuclear Medicine|December 6, 2018
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016Sied Kebir, Manuel Weber, Lazaros Lazaridis, et al.Cancer Medicine|April 2, 2026
Regrowth Patterns in Glioblastoma-Survival and PredictorsJonas A Feldheim, Jana Grieger, Teresa Schmidt, et al.BMC Public Health|March 23, 2024
Pregnancy health in a multi-state U.S. population of systemically underserved patients and their children: PROMISE cohort design and baseline characteristicsJanne Boone-Heinonen, Kristin Lyon-Scott, Rachel Springer, et al.Cancers|February 13, 2026
COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy AdultsTeresa Schmidt, Mirko Trilling, Vu Thuy Khanh Le-Trilling, et al.Pageof 7